The LINE-1 retrotransposon (L1) encodes two proteins, ORF1p and ORF2p, which bind to the L1 RNA in cis , forming a ribonucleoprotein (RNP) complex that is critical for retrotransposition. Interactions with both permissive and repressive host factors pervade every step of the L1 life cycle. Until recently, limitations in detection and production precluded in-depth characterization of L1 RNPs. Inducible expression and recombinant engineering of epitope tags have made detection of both L1 ORFs routine. Here, we describe large-scale production of L1-expressing HEK-293T cells in suspension cell culture, cryomilling and affi nity capture of L1 RNP complexes, sample preparation for analysis by mass spectrometry, and assay using the L1 element amplifi cation protocol (LEAP) and qRT-PCR.
Introduction
LINE-1 is the only active protein-coding transposon in humans. Hundreds of thousands of copies of L1 make up ~20 % of the human genome and are a source of genetic structural variation and between humans and instability in cancer [ 1 -4 ] . Although most L1s are truncated or mutated, ~90 copies per cell are capable of replication [ 5 ] . As a streamlined DNA parasite with which we have coevolved since early eukaryotic existence [ 1 ] , L1 encodes only two proteins and coopts cellular machinery in order to replicate. To defend against L1-mediated mutagenesis, our cells possess multiple mechanisms to suppress its activity [ 6 -18 ] . Although teleological roles of retrotransposition in evolution are somewhat controversial [ 19 -21 ] , critical interactions with the host functions are highly conserved; for example, the PIP box, a motif required for L1 ORF2p -PCNA binding and retrotransposition, is conserved from corn to humans [ 6 ] .
L1 ORFs bind the L1 mRNA to form a ribonucleoprotein ( RNP ) complex [ 22 , 23 ] . ORF1p is a trimeric nucleic acid binding protein that is highly expressed in human cancers and cell culture models and thought to have chaperone activity; it is required for retrotransposition but its precise role is unknown [ 24 -29 ] . ORF2p possesses both endonuclease and reverse transcriptase activities [ 30 , 31 ] and, in contrast to ORF1p, is expressed at such low levels even after overexpression (due to an unconventional translation mechanism) that detection was a technical barrier in the fi eld until recently [ 6 , 32 , 33 ] . However, the combination of a tetracycline-inducible promoter and improved epitope tagging now makes detection and purifi cation of both ORFs routine [ 6 ] , reviewed in [ 34 ] . A synthetic codon-optimized L1, ORFeus -Hs [ 35 , 36 ] , produces ~40-fold more L1 RNA and ORF2p and was critical to establishing protocols for purifi cation of ORF2p; interactors were similar to native L1RP [ 6 ] .
Here, we outline our methods for suspension production, cryomilling, and affi nity capture of L1 RNPs with subsequent characterization by mass spectrometry , the L1 element amplifi cation protocol ( LEAP ) [ 23 ] , and quantitative real-time reverse transcription PCR ( qRT-PCR ). Suspension production improves cell densities as compared to adherent cell culture, and allows for suffi cient cell material for solid-phase lysis under liquid N 2 by cryomilling. This approach has a number of practical advantages over liquid-phase lysis including reduced background in coimmunoprecipitation and the ability to store the milled cell powder at −80 °C, allowing repeated experiments to be performed from the same sample without the need to produce more starting material [ 37 , 38 ] .
We express inducible L1 in Tet-On HEK-293 LD cells using pCEP4-based episomal vector s and either large-scale transient transfection or quasi-stable episomal puromycin -selected cell pools [ 6 ] . Because no Tet-On HEK-293T cells were available commercially, we produced this line using a linearized pTet-On Advanced (Clontech), modifi ed to contain blasticidin resistance instead of neomycin (pLD215). Cells are maintained in square bottles on an orbital shaker [ 39 ] . Alternative systems include GNTI-HEK293S cells, HEK-293F cells (Life Technologies), and the T-REx system (Life Technologies), and can be achieved in spinner fl asks, conical fl asks, and wave bags [ 40 , 41 ] .
For L1 affi nity isolation, we couple antibody to functionalized micron-scale paramagnetic beads with relatively inert surfaces ( Dynabeads , Life Technologies). After coupling, antibody is immobilized on the surface of the bead. For the isolation of protein complexes, these beads provide a number of advantages over agarose and porous synthetic resins (which both contain antibody bound within the pores) including the ability to bind and release larger complexes, faster binding and release, and reduced background [ 37 , 38 , 42 ] . Switching to this medium was critical for the successful characterization of L1 RNPs. L1 RNPs purifi ed by affi nity capture provide the purest, most active L1 elements reported to date and are excellent starting material for assay by mass spectrometry , LEAP , and qRT-PCR [ 6 ] . We provide several of our working protocols for L1 sample preparation and analysis.
Materials
1. Humidifi ed CO 2 -controlled tissue culture incubator.
2. Orbital shaker platform at 130 rpm fi tted with racks.
3. 20 mm 40-place test tube racks.
4. Diagonal cutting pliers, fl at wood fi le, bandsaw (for modifying racks).
5. Corning Pyrex 1 L glass bottles.
7×
® Cleaning solution (Bellco Glass).
7. Hybridoma SFM medium (Life Technologies).
Freestyle 293 Medium (Life Technologies).
9. Opti-MEM Reduced Serum Medium.
TrypLE Express (Life Technologies).
11. Certifi ed tetracycline-Free FBS (Tet-free FBS).
12. DMEM medium.
13. Phosphate-buffered saline (PBS).
14. PEI Max (MW 40,000), Polysciences: Two grams is enough to transfect >600 L.
(a) To prepare working 1 mg/mL PEI Max solution:
(b) Dissolve 100 mg PEI Max in 90 mL ddH 2 O.
(c) Adjust pH to 7.0 using 1 M NaOH.
(d) Adjust volume to 100 mL, fi lter sterilize, and store at 4 °C.
(e) NEVER FREEZE PEI working stock . Working stocks can be used for up to 6 months if stored at 4 °C.
15. Large-volume fl oor centrifuge with appropriate rotor (e.g., 4 × 1 L, 6 × 500 mL).
16. 16ga needles.
17. Luer-lock syringes, 5 mL, 10 mL, or 30 mL.
18. Luer-lock syringe end caps (BioRad).
19. Liquid nitrogen and Dewar fl ask .
20. Gloves for handling liquid nitrogen.
21. Small Styrofoam box. 51. LEAP reaction mixture (Table 1 ) , shown for ten reactions. Table 2 ). 
Suspension Cell Culture

Cell Harvest
Primers for LEAP and qRT-PCR ( see
Methods
Suspension culture allows production of large amounts of human cell pellets with minimal work, waste, and cost when compared to monolayer adherent growth. We use a square bottle system in an orbital shaker, modifi ed from [ 39 ] (Fig. 1a ) . For comparison, one confl uent 15 cm plastic adherent culture dish provides about 100 mg wet cell weight (cell pellet, WCW), corresponding to 20-30 million cells, and uses 20 mL of media. To produce 1.5 g of cell pellet, 15 disposable dishes and 300 mL of media are required, and scale up, induction, and harvest are laborious. In suspension, cell densities of 4-5 million cells/mL are readily achieved in log phase using reusable 1 L glass bottles, yielding 4-5 g WCW from 333 mL media. Thus, each bottle is the equivalent of approximately 50 culture plates. The total yield from 48 culture bottles (Fig. 1a ) was approximately 250 g WCW and was harvested in 90 min by one person; an entire incubator full of plates (Fig. 1b ) produced 16 g WCW and was harvested in 4 h by two people. We culture Tet-On HEK-293T LD cells in Freestyle 293 medium supplemented with 1 % tetracycline-free FBS and 2 mM l -glutamine (suspension medium, see Note 6 ). Basic shaker setup and maintenance are described below. Initially, for each construct we 1. Cut tube racks to fi t bottle confi gurations (Fig. 1c ) . Use diagonal cutting pliers to remove undesired dividers and then a fl at wood fi le to smooth sharp edges. To shorten racks, cut to length with a bandsaw. We start with 10 × 4 racks and cut most racks to fi t two 1 L glass bottles, a confi guration with two 4 × 4 openings as shown. Other confi gurations or other size starting racks would allow use of alternate or smaller bottles.
Suspension Culture of HEK-293T Cells
2. Clean and autoclave racks before installation.
3. Install racks to shaker platform using stainless steel fl at-head machine screws and, if needed, washers. The bottom of the racks may need to be drilled.
4. Use paper tape between the racks to hold weak sections together.
1. Clean freshly gloved hands with 70 % ethanol before going into the shaker cabinet.
2. Media is maintained at up to 33 % of the indicated capacity for optimal mixing and gas exchange.
(a) Minimum volume is 5 % of indicated capacity (50 mL for 1 L bottles).
(b) Cell shearing is inversely proportional with bottle size; too little volume can result in excessive shearing.
3. Bottle caps are kept loose to allow gas exchange, but not loose enough to easily fall off.
4. The outsides of bottles are wiped clean before returning to the shaker.
5. After use, bottles must be immediately rinsed and fi lled with tap water. Bottles are left soaking until they are ready to clean. A small number of "beached" cells stuck to the side of the glass at the media-air interface is normal for bottles that have been used for a number of weeks.
6. When a batch of bottles is ready for sterilization, bottles are thoroughly scrubbed with a brush cleaned using 1 % solution of 7× cleaner, rinsed six times using tap water, and fi nally rinsed with deionized water.
7. Bottles are sterilized by autoclaving using a dry cycle at 121 °C, with 45-min sterilization and 15-min drying. See Note 8 .
8. In the event of contamination, bottles are soaked in 10 % bleach for at least 2 h and then washed and autoclaved as above. See Note 9 .
Bottles and Volumes
1. Most operations are done by pouring. Be careful to consider that only the threads of the bottle are sterile.
2. Do not allow non-sterile bottle sides to be positioned over the mouth of an open bottle. If a bottle is to be totally emptied, we pipet the last ~40 mL.
3. Caps are stored face-down on the hood. Remember that the hood surface and the rim of the cap are never sterile but the cap threads and inside are sterile.
4. This media has no pH indicator dye, but one can be added if desired.
5. Cells are generally maintained at a density of ~0.2-4 million/ mL ( see Note 10 ). Cells will grow to ~7 million/mL [ 39 ] but growth slows after ~5 million/mL.
6. We do not spin the cells down to fully exchange media. Passaging is done by dilution. Centrifugation is time consuming, risks contamination, and is generally not helpful. HEK-293Ts grow in small clumps of 1-30 cells in suspension. Accurate counting requires dissociation of the clumps by gentle trituration using a pipet. Due to differences in light scattering by different clump sizes, optical density is not an accurate measure of cell number. We visualize the cells before and after dissociation because shearing in the dissociation protocol lyses a small fraction of the cells. (e) Incubate for 15 min at room temperature to allow DNA-PEI complex to form.
(f) Pipet 16.7 mL into each 333 mL culture and return to the incubator. Transfection is done on 6-well plates and followed by a puromycin selection done simultaneously with scale-up and transition to suspension medium. Adherent cells are maintained in DMEM supplemented with 10 % tetracycline-free FBS and penicillin-streptomycin (adherent medium). ii. Dissociate and count the cells. Remove the media.
iii. Resuspend the cells in 10 mL media and triturate aggressively to break up clumps. Increase volume to 50 mL (typically ~1 million/mL), transfer to a 1 L bottle, and immediately put in the shaker.
(f) Days 9-11: Check the cells after 2 days in suspension. Typical density should be >2 million per mL. Cultures are typically very clumpy at this point, but healthy and doubling every 24-36 h. Sometimes the clumps are large enough to see by the naked eye. The goal of the following steps is to reduce the serum concentration and select nonclumping cells.
i. Transfer 25 mL of the culture (50 mL) into each of the two 50 mL conical tubes.
ii. Triturate fi ve times.
iii. If the cells are very clumpy, vortex three pulses of 5 s (maximum intensity) to break up clumps.
iv. Transfer tubes to a rack in the hood. Count the cells. While counting, allow the cells to settle for a total of 5 min; large clumps will settle rapidly.
v. Split the cells to 0.5 million per mL, adding only suspension medium.
vi. Remaining cells may be used for a test induction at this point.
(g) Expand cells to desired volume and induce at 3.5-4.5 million/mL with 1 μg/mL doxycycline. Harvest 24 h later ( see Note 26 ).
L1-RNPs
Cells are spun down in syringes and injected into tubes containing liquid nitrogen [ 38 ] . A video protocol of this process done in yeast cells is available at http://www.ncdir.org/public-resources/protocols/ . The below protocol is modifi ed for human cells.
1. Gather an ice bucket and clean centrifuge bottles.
2. Count cells. Counts are useful for normalization and blotting.
3. Transfer a 1 mL aliquot(s) of culture for western blotting to a microcentrifuge tube. Spin at 500 × g for 30 s, aspirate the media, and store on ice until freezing is convenient.
4. Spin the cultures at 1000 × g for 10 min at 4 °C to pellet. We use both 4 × 1 L and 6 × 500 mL centrifuge rotors ( see Note 28 ). Pour off the media.
5. Resuspend the pellets in a minimal volume of PBS (approximately equal volume to the pellet). Pool resuspended cells.
6. Pellet cells inside syringes. (Fig. 2 ).
8. Pre-chill a small stainless steel spatula, standing it vertically in the liquid nitrogen.
9. Punch a number of holes in the caps of the tubes using a 16ga needle. This allows drainage of the LN 2 without loss of cells.
10. Inject the cells gradually into the tube containing LN 2 ( Fig. 2 ) ( see Note 33 ). If injected too fast, they will form large clumps. Use the pre-chilled spatula as needed to break apart any clumps.
11. Cap the tube using the punched lid. Careful! Pressure will build up and liquid can shoot out. Decant into a sink. Replace the punched lid with a new, intact lid and store tubes at −80 °C until cryomilling ( see Note 34 ).
Harvest of Suspension Cells to Make Liquid Nitrogen "BB's" ( See Note 27 )
We cryomill cells under liquid nitrogen in a Retsch PM 100 planetary ball mill; model PM 100 CM is also suitable. A newer model, the CryoMill, may be suitable for smaller samples. This protocol was initially developed for yeast, which are harder to break than mammalian cells due to the tough cell wall, and then adapted for mammalian cells with two stages of grinding [ 38 ] . Depending on the amount of cells to grind, we either use a 50 mL jar (~1-8 g cells) or a 125 mL jar (~5-30 g cells, Fig. 3a ) ( see Note 35 ). We present here a simplifi ed protocol, after fi nding that the second stage of grinding was not necessary (Fig. 3b ) . Custom-made PTFE insulators (Fig. 3a ) minimize warming of the sample during grinding and improve safety and performance ( see Note 36 ). We use a homemade LN 2 decanter made using a spatula and 50 mL conical tube to pour LN 2 into and over the grinding jars [ 38 ] .
1. Pre-clean grinding jar, lid, balls, two small steel spatulas, and large forceps using Windex glass cleaner or similar. Inspect the PTFE gasket for signs of damage. For a 50 mL chamber, use two 20 mm diameter balls. For a 125 mL chamber, use fi ve 20 mm diameter balls.
2. Weigh the jar + insulators + balls and adjust PM 100 counterbalance accordingly.
3. Precool the jar, balls, spatulas, forceps, LN 2 decanter, and PTFE insulators in a clean Styrofoam box containing liquid LN 2 until the LN 2 stops boiling ( see Note 37 ). Set up a working pan with LN 2 ( see Note 38 ). (a) Pour LN over the jar using the decanter to cool the lid and top.
Cryomilling
(b) Some pressure will have built up during the grinding. The jar may be gently hissing as pressure escapes: this is normal. Carefully remove the jar as in step 9 below and transfer to the pan of LN 2 to recool.
(c) Remove the lid and use a spatula to scrape any adhered powder back into the chamber. Do not scrape the gasket with a spatula: it will damage the PTFE seal. Submerse the lid to cool. This protocol was originally developed for bulk rabbit IgG [ 37 ] and has been adapted for use with precious/expensive antibodies, like anti-Flag M2. See also [ 44 ] for a general protocol. Nucleophilic side chains and N-termini on the antibody react with epoxide functional groups on the bead surface. It is critical that all other nucleophiles are absent from the buffer, or these will react with the beads and prevent antibody coupling . This includes tris, glycerol, azide, and other common antibody buffer components. It is safest to buffer exchange antibodies from commercial sources unless the absence of nucleophiles can be assured.
We exchange the buffer twice to remove as much contaminant as possible. For large-scale couplings, we use a fast protein liquid chromatography (FPLC) system (ÄKTA, GE Healthcare) with a preparative-scale desalting column, but in the absence of this equipment, and for small, precious antibody samples, we use the below protocol. Alternative methods include ion exchange and dialysis. 3. Transfer to a 15 mL falcon tube and wash the bottle twice with 2 mL phosphate buffer ( see Note 47 ).
4. Shake bead suspension for 10 min on a nutating mixer or orbital shaker.
5. While the beads mix, prepare the antibody mixture (20 μL/mg Dynabeads , 6 mL total). (c) 0.1 M Phosphate buffer to 6 mL.
Transfer beads to a magnetic separator ( see Note 48
). Aspirate the buffer.
7. Wash again with 10 mL 100 mM phosphate buffer. Add buffer, vortex for 15 s, apply magnet, and aspirate; no incubation is necessary.
8. Add the antibody mixture to the beads. Seal and Parafi lm the tube, and mix well.
Incubate overnight (18-24 h) on a rotating wheel at 37 °C ( see Note 49 ).
Day 2: Bead Washing 1. Separate beads from the antibody mixture with a magnet. Carefully remove the antibody mixture and set aside in a clean tube: it still contains 30-50 % of the antibody, unreacted, which can be recovered for reuse.
2. Wash beads once with 12 mL 100 mM glycine pH 2.5. Add buffer, vortex briefl y, and take it off as fast as possible.
3. Wash once with 12 mL 10 mM Tris-HCl, pH 8.8.
4. Prepare fresh 100 mM triethylamine: Add 168 μL stock to 11.8 mL ddH 2 O. Apply, mix, remove, and proceed to the next step as fast as possible.
5. Wash the beads with 12 mL 1× PBS, incubating for 5 min on the nutator. Repeat a total of four times.
6. Wash twice with 12 mL PBS + 0.5 % Triton X-100, incubating each wash for 10 min on the nutator.
7. Resuspend beads in 2 mL resuspension buffer: PBS, 50 % glycerol, and 0.5 mg/mL BSA ( see Note 50 ).
8. Mix well and aliquot 100 μL each into Eppendorf tubes. Store at −20 °C ( see Note 50 ).
Reuse and Optional Antibody Recovery Using Protein G affi nity ( see Note 51
). Approximately 30-50 % of antibody is unbound after coupling. We routinely save antibody mixtures for use in other assays such as immunoblotting and immunofl uorescence. Alternatively, recovered antibody can easily be re-captured using Protein G affi nity. Recovery also allows concentration of antibody and transfer into a more permanent storage buffer. We use Protein G Sepaharose Fast Flow (GE Healthcare) ( see Note 52 ) following the manufacturer's instructions. The antibody sample should be diluted with an equal volume of PBS for binding. Based on 50 % antibody-Dynabead binding, ~125 μL resin is needed for recovery after a 300 mg Dynabead coupling. After elution, add 50 % glycerol for storage or dialyze or desalt into the buffer of choice.
For a comprehensive review of considerations affecting expression systems, epitope tagging, and affi nity medium choice see [ 45 ] . In brief, we fi nd that Dynabeads , when conjugated to high-quality antibodies, provide for excellent quality recovery of endogenous protein complexes from human cells [ 37 , 38 ] . We have successfully applied this approach to L1 RNPs [ 6 ] . For purifying 3× Flag-tagged constructs, α-Flag Dynabeads are necessary, prepared as above. When combined with neodymium magnet racks, antibodyconjugated magnetic medium (beads) is rapidly separated from the buffer and immobilized on the side of the tube. This allows nearcomplete aspiration of buffer without the risk of aspirating the beads. i. Repeat (a) for as many purifi cations as you will carry out.
ii. Multiple purifi cations can be pooled after elution if larger scale is required.
(b) Move the tubes to room temperature for 1-2 min ( see Note 54 ).
Affi nity Capture of RNPs Using Conjugated Magnetic Medium
L1-RNPs (c) Add 800 μL of extraction solution ( see Note 55 ) (20 mM Na-HEPES pH 7.4, 500 mM NaCl, 1 % v/v Triton X-100; plus protease inhibitors) to each tube, vortex for ~30 s until powders are resuspended, and then place the crude extracts on ice. Some membrane aggregates may be observed ( see Note 56 ).
(d) Sonicate each tube with a micro-tip probe on a low-power setting using 2 × 2 s pulses. Membrane aggregates should no longer be visible ( see Note 57 ).
(e) Centrifuge for 10 min at full speed (20-30,000 RCF) in a refrigerated microcentrifuge at 4 °C.
i. During this step the affi nity medium can be pre-washed ( step 2a ).
(f) Remove supernatant-this is your clarifi ed extract-and add to the tube containing α-Flag Dynabeads ( step 2b ).
i. Set a fraction aside before combining with beads to compare pre-and post-bead binding ( step 2ci ) in order to assess the effi cacy of the affi nity capture .
Affi nity capture :
(a) Prepare beads:
i. Pipette 20 μL of α-Flag Dynabeads slurry into a 1.5 mL microcentrifuge tube ( see Note 58 ).
ii. Repeat for each affi nity purifi cation to be carried out.
iii. Wash the beads twice with 500 μL of extraction solution.
iv. Remove the supernatant, and hold the beads on ice until needed.
(b) Combine the clarifi ed extract ( step 1f ) with the beads.
i. Incubate at 4 °C for 30 min ( see Note 59 ).
(c) Separate beads on a magnetic separator. Set a fraction aside to compare with input ( step 1fi ), and aspirate the remainder.
(d) Wash the beads with 1 mL of extraction solution and then remove the supernatant. Wash protocol for beads (used throughout):
i. Add buffer, and vortex at full power for 2-3 s.
ii. Pulse-spin in a benchtop microcentrifuge to remove any magnetic beads from the cap.
iii. Separate beads on a magnetic separator, and remove buffer using a vacuum aspirator.
(e) Resuspend the beads in 1 mL of extraction solution, transfer to a fresh microcentrifuge tube, and then remove the supernatant ( see Note 60 ).
(f) Wash again with 1 mL of extraction solution.
(g) Elute the L1 RNPs from the beads with 26 μL of 1 mg/ mL 3× Flag peptide in extraction solution (native) or using 1× SDS-PAGE loading buffer without reducing agent ( see Note 61 ).
i. Native elution: Incubate for 15-30 min at room temperature with gentle agitation (just enough to mix and suspend the beads).
ii. Denaturing elution: Incubate for 5-10 min at 70 °C with moderate agitation ( see Note 62 ).
iii. If native elution is used, remove the eluate and then perform a second denaturing elution to assess the efficacy of the native elution.
3. Natively eluted samples can be carried forward to other assays (see LEAP and RT-PCR below) and/or subsequently prepared for SDS-PAGE ( see Notes 63 -65 ).
4. For samples to be analyzed by mass spectrometry , reduce and alkylate with iodoacetamide:
(a) Add SDS-PAGE loading dye to 1× and DTT to 20 mM ( see Note 66 ). (e) Load directly on a gel.
Proper preparation of samples is critical for mass spectrometry as a number of interfering species can reduce sensitivity and compromise protein identifi cation (for discussion and advice, see [ 45 ] ). For identifi cation of the most prominent species, readily observed by standard protein staining techniques (reviewed in [ 46 , 47 ] ), we excise regions of the gel containing stained protein bands and use MALDI-MS peptide mass fi ngerprinting (PMF, [ 48 , 49 ] ; example protocols that we use can be found in the supplement of [ 38 ] ). For more sensitive detection and identifi cation of the complement of proteins within the sample we use liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS) approaches (reviewed in [ 50 , 51 ] ). If proteins are fi rst metabolically labeled with stable isotopes prior to affi nity capture , then isotopic differentiation of interactions as random or targeted (I-DIRT) can be implemented. This MS-based analysis provides statistical discrimination between interactors likely to have originated in vivo and those likely to be in vitro artifacts, and can be accomplished by modifying the procedures outlined in this chapter [ 6 , 52 , 53 ] . Whether MALDI-MS or LC-MS/MS will be used, we prefer gel-based peptide sample
Sample Preparation for Mass Spectrometry
L1-RNPs work-up [ 54 ] . Because different MS-based analytical approaches may require different sample work-up procedures, we recommend adopting appropriate procedures based on the preferences of your proteomics core facility or collaborator.
This protocol uses ORF2p reverse transcriptase and an anchor primer to reverse transcribe bound RNA [ 23 ] . cDNA is then amplifi ed by PCR for visualization on a gel or quantifi cation by real-time PCR. A boiled sample is used for a negative control. cDNA is made with commercial reverse transcriptase as a positive control.
1. Thaw RNPs on ice. Clean bench and work area using RNAseZap or similar. Open a clean box of pipet tips. 1. Aliquot 2 μg purifi ed GFP-transfected control RNA into each tube.
2. Add 10 μL of each RNP sample, and mix well.
3. Purify RNA using TRIzol Reagent according to the manufacturer's protocol.
4. Resuspend RNA in 20 μL RNase-free water.
5. Quantify by qRT-PCR as in Subheading 3.8 , step 10 , using 0.5 μL resuspended RNA in triplicate. Primers for GFP (JB13766 and JB13767) are used for normalization of each sample.
Notes
1. This affi nity-purifi ed version performs as well or better than the non-affi nity-purifi ed F3165, and at the time of writing is approximately half the cost.
2. The Dynamag 15 rack is useful for couplings starting with 300 mg Dynabeads . We often do smaller test couplings with 60 mg Dynabeads, which can be done with 2 mL tubes. To reduce cost, high-quality neodymium magnets from MAGCRAFT are widely distributed and available in a variety of shapes. These can be fi tted into homemade racks or attached to tubes using rubber bands; arc-shaped magnets are particularly useful with rubber bands.
3. The pH of 10× PBS is between 6.6 and 6.7 at 10× but is 7.4 when diluted to 1×.
4. Buffer components for affi nity capture and LEAP should be RNase free, and handled with precautions for cleanliness appropriate for RNA work. This includes buffers used for dissolution of 3× Flag peptide, etc..
5.
We transfect HEK-293TLD cells with pCAG-eGFP (Addgene # 11150) and purify total RNA using an RNeasy mini kit (Qiagen).
6. Life Technologies reports that Freestyle 293 provides serumfree growth of their engineered HEK-293-F cells. In our experience with other HEK-293 and HEK-293T cells, 1 % tet-free FBS adds little cost to the medium and increases reliability. Similarly, supplemental l -glutamine, added fresh, provides more reliable growth than their GlutaMax alternative alone. We make a 50:50 mix of serum and 200 mM l -glutamine , fi lter, and add 20 mL per liter.
L1-RNPs 7. We have been unable to establish an effective protocol for puromycin selection after suspension transfection.
8. Always autoclave with loose bottle caps. The tops of the bottles can be covered in foil for additional protection. After the autoclave fi nishes, transfer bottles to a culture hood to cool, and then tighten caps for storage.
9. If any bottle is found to be contaminated, all bottles in the incubator must be checked for signs of contamination.
10. Until a suspension line is well established or after steps that can be toxic to cells, we fi nd a minimum density of 0.5 million/mL is safer than 0.2 million/mL.
11. Do not directly transfer from the serological pipet to the hemocytometer .
12. Never use a micropipettor in suspension bottles: this risks contamination.
13. This ratio should be optimized for different cell lines and DNA preparation methods.
14. After column purifi cation, precipitate with isopropanol and wash with ethanol. DNA prepared with their precipitator modules has been less effective in our experience.
15. To save time, hybridoma SFM aliquots can be left at room temperature overnight.
16. For small numbers of transfections, prepare DNA-PEI complex in conical tubes. For larger volumes, use a glass bottle.
17. ORF2p expression peaks 24 h after induction and falls thereafter. ORF1p expression peaks at ~18 h after induction and is constant for at least 4-5 days. Harvest time should be optimized for your protein of interest.
18. We have found that with episomal pCEP4-based plasmids, a 1:3 "split-back" minimally reduces per-cell yield but allows the use of threefold less DNA per gram WCW.
19. We fi nd that transfection effi ciency is higher in 6-well wells than larger scales, so we transfect a number of wells and then pool the cells later.
20. If protease is used, quench with serum-containing media and centrifuge for 5 min at 200 RCF to remove the protease.
21. Recipe for suspension medium is as described above, but when following the protocol for adherent transfection, selection, and adaptation to suspension it may include antibiotics.
22. Cells can be adapted into higher puromycin concentrations of 2-10 μg/mL, resulting in higher per-cell expression but slower growth and longer time needed for adaptation.
23. Suspension cells are more sensitive to puromycin than adherent cells. 34. Storage with a punched cap is acceptable for a few days; however frost will form on cells over longer periods.
35. 1 g WCW is approximately the minimum amount of cells for grinding. A small amount of material (up to ~500 mg) is lost on the surface of the jar and balls, so practically we aim to produce at least 1.5-3 g WCW.
36
. The custom PTFE insulators are not required for this protocol [ 38 ] . However, we fi nd that grinding is greatly aided by the inclusion of LN within the jar ("wet grinding"). The insulators prevent warming of the jar, evaporation of the nitrogen, and pressure buildup, resulting in faster, more reliable grinds. To have insulators made at the Rockefeller University machine shop, contact the Rout Lab.
37. All tools for grinding should be chilled during use. 44. This results in ~2.2 mL fi nal volume, and a slurry of approximately ~10-15 % by volume.
45. Measurements of coupling yield were done using rabbit polyclonal IgG. The apparent capacity of the beads may vary depending upon the coupling conditions, including the concentration of salt, ammonium sulfate, pH, and temperature of coupling.
46. With anti-Flag M2, beads conjugated at 8 μg antibody/mg Dynabeads do not perform as well as beads conjugated at 10 μg/mg. There is only a marginal improvement in going from 10 to 12.5 μg/mL; we use 10 μg/mg as a cost-effective compromise.
47. Sometimes resuspension requires more volume. Simply remove the buffer from the beads using a magnetic separator and wash the bottle with fresh buffer.
48. The addition of BSA increases the long-term stability of M2-Flag antibody-conjugated Dynabeads .
49. 30 °C is also effective.
50. With proper storage, coupled Dynabeads may be used without loss of performance for >1 year. Alternatively, if the beads will be completely consumed within ~8 weeks, storage at 4 °C is suitable-resuspend with PBS, 0.5 mg/mL BSA, and 0.02 % sodium azide and store at 4 °C. 53. Use a small Styrofoam rack on a microbalance and pre-chill tubes and weighing instruments on LN2. We have found that this is easiest using inexpensive small stainless steel measuring spoons designed for culinary use.
54. Allowing the tube to briefl y warm prevents extraction solution from fl ash freezing on the side of the tube.
55. Determination of the optimal extraction solution for each complex is critical but beyond the scope of this chapter. For more information see LaCava et al. (45) .
56. Hold tubes on ice between each subsequent manipulationworking at room temperature is otherwise acceptable.
57. The power should be adjusted such that the minimum amount of energy is used that will disperse the aggregates. On a Branson Sonifi er with Microtip, this is power setting 3.
58. The ratio of beads to lysate can be optimized. For α-ORF1p pullouts 50 μL Dynabeads were needed to deplete the ORF1p from extracts. For α-ORF2p pullouts, 10 μL was suffi cient and background increased with larger amounts.
59. This time can be optimized. For α-ORF1p pullouts, 5 min was as effective as 30 min. For α-ORF2p pullouts using α-Flag Dynabeads , 1 h was more effective than 30 min.
60. We fi nd that transfer to a fresh tube at this step reduces background because some protein nonspecifi cally sticks to the tube.
61. Reducing agent is omitted to reduce the release of IgG from the beads. It should be added after separation from the magnetic medium, before denaturation for SDS-PAGE.
62. We use a Thermomixer (Eppendorf) at full speed.
63. The advantage of native elution, even if SDS-PAGE is the next step, is its tendency to release only specifi c interactors of the tagged protein , reducing nonspecifi c contamination.
64. Regardless of the elution method, all samples should be reduced and alkylated prior to loading on the gel to maximize sensitive detection of cysteine-containing peptides during subsequent MS.
65. For storage of purifi ed RNPs, for example for future LEAP , we dilute 1:1 with 50 % glycerol (25 % fi nal), fl ash freeze with N2, and store at −80 °C.
66. This is 40 % of the typical 50 mM DTT concentration in reducing SDS-PAGE loading dye.
L1-RNPs
67. Incubation at 50 °C favors the SuperScript III reaction over the ORF2p reaction. At 37 °C both reactions occur simultaneously.
68. These primers are specifi c for ORFeusHS; appropriate primers should be chosen for other L1 elements.
